GI/Liver Pharmacology Flashcards
H2 Antagonists vs. PPIs - pharmacodynamics
H2 are less effective, but ARE good at NOCTURNAL acidity; more rapidly absorped and less protein bound.
Hereditary Hemochormatosis tx
Phelbotomy
chelation with Deferasirox, deferoxamine, deferiprone
Triple Theraty
PPI + Clarithrymycin + Amoxicillin
Adalimumab
TNF-alpha antagonist used to tx IBD
Wilson Dz treamtnt
Copper chelation with D-penicillamine, trientine
Area Postrema
area outside of BBB that is acted on my cancer drugs
Uses of PPI
First line: GERD, PUD, H Pylori triple therapy
NSAID ulcers: Tx and prevention
Prevention of stress gastritis
ZE syndrome
Bidacodyl - ADRs
Dangerous electrolyte and fluid imbalances
most widely abused
interpatient variation
ADRS of PPIs
Very safe
minor side effects of HA, Abdominal pain, N, C, Diarrhea
Increased risk of C diff infection or pneumonia.
Rebound acidity with discontinuation
Cimetidine - type
H2 Receptor antagonist - Anti-acid medication
Pharmacokinetics of PPIs
best if taken before a meal
short half life, but long acting
metabolized by CYP450, dosage reduction required with severe hepatic disease only
Magnesium hydroxide uses and ADRs
used to create osmotic diarrhea to counteract Al and Ca side effects.
Avoid in renal diseases due to retention of Mg
Sulfasalazine
5- Aminosalicylate used to tx IBD
Bidacodyl uses
Constipation that fails fiber and osmotically active.
Opiod constipation
Pharmacodynamics of PPis
prodrug administered into systemic circulation that diffuses into parietalc ells and is activated to sulfanamide and trapped.
Only inactivates ACTIVE pumps - sso delayed effect
Loperamide
Mu opioid agonist that decreases intestinal motility and secretion.
used for travelers diarrhea
ADRS; low addiciton, overdose can cause CNS depression, cardiotoxicity (QT prolongation),
Milk of Magnesia
Used for mild to moderate constipation and opioid constipation.
ADRS: avoid with renal dysfunction due to hypermagnesium
Adsorbent antidiarrheals
Kaolin, pectin, bismuth
used for mild/mod diarrhea - promote formed stool, but little effect on volume secretion.
Avoid subsalicylate in children under 12
Lansoprazole - mechanism and Type
PPI - irreversibly inactivates H/K ATPase pump on Apical side of Parietal cells to decrease Acid secretion
Cisapride ADRs
QT prolongation, life threatening arrythmias
Tegaserod/Cisapride uses
Diabetic Gastroparesis
IBS constipation
IBS- reduced bloating
Mesalamine
5- Aminosalicylate used to tx IBD
Omeprazole - Mechanism and Type
PPI - irreversibly inactivates H/K ATPase pump on Apical side of Parietal cells to decrease Acid secretion
Cisapraide - type
Promotility - agonist of 5HT4 R on ENS ACh.
Acts as Class III antiarrhthmic by blocking K channels
Bidacodyl
Stimulant/irritative laxative
Increases peristalsis by low grade inflammation to promote water accumulation by activating PG, NO, cGMP
Sucralfate - pharmacokinetics
inactive- but activated by pH <4 - best on empty stomach.
Sequential therapy
PPI + Amox for 7 days
PPI + clarithromycin + Metronidazole 7 days
Calcium Carbonate - type and mechanism
Gastric antacid that raise stomach pH
Prochlorperazine ADRs
Extrampyramidal SE
Magnesium Hydroxide - type and mechansim
gastric antacid by being osmotic agent.
Tegaserod
Serotonin 5HT3 agonist to promote gastric emptying and motility.
Renal and hepatic metabolism - contraindicated in renal and liver failure
used for women under 55 with constipation assoc. IBS
ADRs: Diarrhea, MI, stroke, unstable angina
H2 Antagonists - excretion
renal - requires dosage adjustment for renal failure